A truce between U.S. and Chinese leaders on trade tariffs provided boosted global markets on Monday, fuelling a nearly one percent surge on world stocks and pushing emerging currencies higher against the dollar. Ciara Lee reports
The former NRL player is again without a club.
At a public meeting islanders tell Danish ferry firm reliability was their priority for future services.
A Limerick shop lays claim to being Ireland's luckiest after selling its second life-changing ticket.
Conservative candidate Festus Akinbusoye says "he rejects and refutes the findings" of the panel.
The States has approved development guidelines for two news sites in St Peter Port.
One resident has likened the football club's expansion to having a championship club in the village.
Including a long-standing hit sitcom and two original titles
Asked at a BBC London TV hustings whether he had succeeded in bringing Londoners with him on clean air and car travel, he says: ‘We will find out on May 2’
Toyota Motor said on Thursday its global sales and production hit record highs in the year ended March 31, supported by robust demand and the absence of semiconductor supply constraints it had to endure in recent years. Still, Toyota plans to delay the start of its electric vehicle (EV) production in the U.S. and trim domestic production to ensure product safety and quality after a series of scandals at its group firms, the Mid Japan Economist newspaper said. For the year ended March, Toyota said its parent-only global sales rose 7.3% to 10.31 million units year-on-year, surpassing the 10 million mark for the first time, while its output came to 9.97 million units, up 9.2% on the year.
Dijon, France April 25, 2024 -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharmaceuticals company developing products for emergency situations harnessing its proprietary needle-free auto-injectors technology platform ZENEO®, reports its audited financial results for the year ending December 31, 2023. These results are now available on the Company’s website. Key financial information as of December 31, 2023 Crossject’s financial results for the year ending December 31, 2023 have
Coughlan says advocacy for social justice has always been part of her life
Volunteers training to respond to disasters fly out for their final assessment for charity Serve On.
Five candidates vying to become Greater Manchester mayor take part in a special BBC election debate.
The council says allocating special educational needs places takes time and cannot be rushed.
TRAINERS' HOUSE GROUP, STOCK EXCHANGE RELEASE, 25 APRIL 2024 at 8:30 January-March 2024 in brief net sales EUR 2.3 million (EUR 2.8 million), change of -18.3 % compared to the corresponding period of the previous yearoperating result EUR 0.2 million (EUR 0.4 million), 7.3 % of net sales (14.5 %)cash flow from operations EUR 0.2 million (EUR 0.3 million)earnings per share EUR 0.08 (EUR 0.19) Key figures at the end of first quarter of 2024 cash and cash equivalents EUR 1.3 million (EUR 2.5 million
PARIS, April 25, 2024--Regulatory News: Pernod Ricard (Paris:RI):
HUHTAMÄKI OYJ INTERIM REPORT 25.4.2024 AT 8:30 EEST Q1 2024 in brief Net sales decreased 4% to EUR 1,004 million (EUR 1,047 million)Comparable net sales growth was -2% at Group levelReported EBIT was EUR 78 million (EUR 87 million); adjusted EBIT was EUR 99 million (EUR 92 million)Reported EPS was EUR 0.35 (EUR 0.47); adjusted EPS was EUR 0.55 (EUR 0.51)The impact of currency movements was EUR -17 million on the Group's net sales and EUR -2 million on EBIT Key figures EUR million Q1 2024 Q1 2023
Press Release Atos reports first quarter 2024 performance1 Q1 2024 Revenue €2,479m, down -2.6% organically Eviden down -3.9% organically, reflecting continued softness in Americas and the UKTech Foundations down -1.5% organically, reflecting lower scope of work with certain customers in Americas and Central Europe Order entry of €1.6bn for a book-to-bill of 64%, compared with 73% in prior year Eviden book-to-bill at 83%, compared with 79% in prior year, driven by stronger demand in High-Performa
Submitted FDA De Novo application for ARC-EX® System Successfully raised EUR 20M in equity capital Announced positive top-line results from Up-LIFT pivotal study Forged partnership to provide rapid access to US Veterans Health Administration Continued to pioneer brain-computer interface therapies for SCI EINDHOVEN, The Netherlands, April 25, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), a medical technology company creating innovative spinal cord stimulation therapies to restore
SAINT-DOLAY, France, April 25, 2024--Regulatory News: Vinpai (ISIN: FR001400AXT1; ticker: ALVIN), the specialist in the design, manufacture and marketing of functional ingredients based on algae and plants for the food and cosmetics industry, today announces its revenue for the first quarter of 2024.
Yahoo Finance